• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

护理伙伴对科恩-曼斯菲尔德激越量表中行为的评估。

Care partner evaluation of the behaviors in the Cohen-Mansfield Agitation Inventory.

作者信息

Oberdhan Dorothee, Palsgrove Andrew, Houle Christy, Lovell Teya, Levine A Alex, Frangiosa Terry, Biggar Ginny, Comer Meryl

机构信息

Otsuka Pharmaceutical Development and Commercialization, Inc., Global Value and Real-World Evidence, Rockville, MD, United States.

Eli Lilly and Company, Chicago, IL, United States.

出版信息

Front Dement. 2024 Mar 8;3:1328874. doi: 10.3389/frdem.2024.1328874. eCollection 2024.

DOI:10.3389/frdem.2024.1328874
PMID:39081618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11285564/
Abstract

INTRODUCTION

Agitation is a common symptom in patients with Alzheimer's dementia. But agitation can be a heterogeneous symptom, encompassing a diverse array of behaviors exhibited by patients. The Cohen-Mansfield Agitation Inventory (CMAI) is a 29-item scale that is used to systematically assess the frequency and severity of agitation in older adults as rated by a primary caregiver. The CMAI was originally designed for use by professional care givers in institutional care settings. Alzheimer's dementia, however, is associated with a significant burden on family members, who provide the majority of care, and other informal care partners.

METHODS

Our qualitative study aimed to assess the accuracy and applicability of the CMAI according to the needs and perceptions of non-professional care partners. Specifically, we wanted to determine if the behaviors included in the instrument reflect: (a) the care partner's experience with agitation in Alzheimer's dementia patients, (b) how the behaviors and their frequency are related to the perception of agitation severity, and (c) what changes in agitation behaviors are meaningful to care partners. We interviewed 30 care partners for patients with Alzheimer's dementia in the United States.

RESULTS

The care partners confirmed all behaviors listed in the CMAI as relevant. The behaviors reflect a spectrum of severity, with aggressive behaviors considered more severe than non-aggressive behaviors and physical behaviors generally considered more severe than verbal behaviors. Any reduction or increase in the frequency of a behavior was meaningful to care partners. Generally, a change from physical to verbal behaviors and aggressive to non-aggressive was considered a meaningful improvement while a change from verbal to physical and non-aggressive to aggressive was considered a meaningful worsening.

DISCUSSION

The CMAI appropriately captures relevant behaviors of agitation in Alzheimer's dementia and provides insight into the relative improvement or worsening of agitation symptoms.

摘要

引言

激越行为是阿尔茨海默病痴呆患者的常见症状。但激越行为可能是一种异质性症状,涵盖患者表现出的一系列不同行为。科恩-曼斯菲尔德激越行为量表(CMAI)是一个包含29个条目的量表,用于由主要照料者对老年人激越行为的频率和严重程度进行系统评估。CMAI最初设计供机构护理环境中的专业照料者使用。然而,阿尔茨海默病痴呆给提供大部分照料的家庭成员及其他非正式照料伙伴带来了沉重负担。

方法

我们的定性研究旨在根据非专业照料伙伴的需求和认知来评估CMAI的准确性和适用性。具体而言,我们想确定该量表所包含的行为是否反映:(a)照料伙伴在阿尔茨海默病痴呆患者中遇到激越行为的经历;(b)这些行为及其频率与激越严重程度认知之间的关系;(c)激越行为的哪些变化对照料伙伴有意义。我们采访了美国30名阿尔茨海默病痴呆患者的照料伙伴。

结果

照料伙伴确认CMAI中列出的所有行为均相关。这些行为反映了一系列严重程度,攻击性行为被认为比非攻击性行为更严重,身体行为通常比言语行为更严重。任何行为频率的减少或增加对应照料伙伴都有意义。一般来说,从身体行为转变为言语行为以及从攻击性行为转变为非攻击性行为被认为是有意义的改善,而从言语行为转变为身体行为以及从非攻击性行为转变为攻击性行为则被认为是有意义的恶化。

讨论

CMAI适当地捕捉了阿尔茨海默病痴呆中激越行为的相关表现,并能深入了解激越症状的相对改善或恶化情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fb/11285564/7d13792cbb95/frdem-03-1328874-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fb/11285564/6294377be7fc/frdem-03-1328874-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fb/11285564/0d973e9dccb0/frdem-03-1328874-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fb/11285564/7d13792cbb95/frdem-03-1328874-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fb/11285564/6294377be7fc/frdem-03-1328874-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fb/11285564/0d973e9dccb0/frdem-03-1328874-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5fb/11285564/7d13792cbb95/frdem-03-1328874-g0003.jpg

相似文献

1
Care partner evaluation of the behaviors in the Cohen-Mansfield Agitation Inventory.护理伙伴对科恩-曼斯菲尔德激越量表中行为的评估。
Front Dement. 2024 Mar 8;3:1328874. doi: 10.3389/frdem.2024.1328874. eCollection 2024.
2
Defining a clinically meaningful within-patient change threshold for the Cohen-Mansfield Agitation Inventory in Alzheimer's dementia.确定阿尔茨海默病性痴呆患者中Cohen-Mansfield激越量表具有临床意义的患者内变化阈值。
Front Neurol. 2024 Jul 23;15:1379062. doi: 10.3389/fneur.2024.1379062. eCollection 2024.
3
Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study.使用科恩-曼斯菲尔德激越量表评估阿尔茨海默病患者的激越模式。阿尔茨海默病协作研究。
Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S45-50. doi: 10.1097/00002093-199700112-00007.
4
Agitation and aggression in people living with dementia and mild cognitive impairment in shared-housing arrangements - validation of a German version of the Cohen-Mansfield Agitation Inventory-Short Form (CMAI-SF).共居环境中痴呆和轻度认知障碍患者的激越和攻击行为 - 中文版 Cohen-Mansfield 激越量表短表(CMAI-SF)的验证。
Health Qual Life Outcomes. 2023 May 29;21(1):51. doi: 10.1186/s12955-023-02132-y.
5
Psychometric evaluation of the Cohen-Mansfield Agitation Inventory in an acute general hospital setting.Cohen-Mansfield 激越量表在综合医院环境中的心理计量学评估。
Int J Geriatr Psychiatry. 2018 Jan;33(1):e158-e165. doi: 10.1002/gps.4741. Epub 2017 May 31.
6
Validation of the Cohen-Mansfield Agitation Inventory Observational (CMAI-O) tool.验证 Cohen-Mansfield 激越观察量表(CMAI-O)工具。
Int Psychogeriatr. 2020 Jan;32(1):75-85. doi: 10.1017/S1041610219000279.
7
Reliability and Validity of a Chinese Version of the Cohen-Mansfield Agitation Inventory-Short Form in Assessing Agitated Behavior.中文版 Cohen-Mansfield 激越量表短式评估激越行为的信度和效度。
Int J Environ Res Public Health. 2022 Aug 1;19(15):9410. doi: 10.3390/ijerph19159410.
8
[Dimensions of Agitation Based on the Cohen-Mansfield Agitation Inventory in Patients with Dementia].[基于科恩-曼斯菲尔德激越量表的痴呆患者激越维度]
Turk Psikiyatri Derg. 2015 Summer;26(2):116-22.
9
Validation of the Cohen-Mansfield Agitation Inventory Observational (CMAI-O) tool - ERRATUM.科恩-曼斯菲尔德激越量表观察版(CMAI-O)工具的验证——勘误
Int Psychogeriatr. 2020 Feb;32(2):287. doi: 10.1017/S104161021900053X. Epub 2019 Jul 2.
10
Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study.队列研究中阿尔茨海默病患者激越和攻击的纵向病程:A3C 研究的方法、基线和纵向结果。
J Prev Alzheimers Dis. 2021;8(2):199-209. doi: 10.14283/jpad.2020.66.

引用本文的文献

1
Defining a clinically meaningful within-patient change threshold for the Cohen-Mansfield Agitation Inventory in Alzheimer's dementia.确定阿尔茨海默病性痴呆患者中Cohen-Mansfield激越量表具有临床意义的患者内变化阈值。
Front Neurol. 2024 Jul 23;15:1379062. doi: 10.3389/fneur.2024.1379062. eCollection 2024.

本文引用的文献

1
2022 Alzheimer's disease facts and figures.2022 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2022 Apr;18(4):700-789. doi: 10.1002/alz.12638. Epub 2022 Mar 14.
2
The Symptoms Targeted for Monitoring in a Web-Based Tracking Tool by Caregivers of People With Dementia and Agitation: Cross-Sectional Study.痴呆症和躁动患者的护理人员在基于网络的跟踪工具中进行监测的目标症状:横断面研究
J Med Internet Res. 2019 Jun 28;21(6):e13360. doi: 10.2196/13360.
3
Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia.
利用电子健康记录估计阿尔茨海默病/痴呆患者的激越发生率。
Int J Geriatr Psychiatry. 2019 Mar;34(3):420-431. doi: 10.1002/gps.5030. Epub 2018 Dec 27.
4
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms.阿尔茨海默病的神经精神症状:新的治疗模式。
Alzheimers Dement (N Y). 2017 Aug 5;3(3):440-449. doi: 10.1016/j.trci.2017.07.001. eCollection 2017 Sep.
5
Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning.阿尔茨海默病中的激越与易怒:循证治疗及黑框警告
Curr Psychiatry Rep. 2016 Jan;18(1):3. doi: 10.1007/s11920-015-0640-7.
6
Advancements in the treatment of agitation in Alzheimer's disease.阿尔茨海默病激越治疗的进展
Expert Opin Pharmacother. 2015;16(11):1649-56. doi: 10.1517/14656566.2015.1059422.
7
Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.认知障碍中的激越:国际老年精神病学协会临时共识临床与研究定义
Int Psychogeriatr. 2015 Jan;27(1):7-17. doi: 10.1017/S1041610214001963. Epub 2014 Oct 14.
8
Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.美金刚用于中度至重度阿尔茨海默病的激越/攻击行为和精神病:三项研究的汇总分析
J Clin Psychiatry. 2008 Mar;69(3):341-8. doi: 10.4088/jcp.v69n0302.
9
Disruptive behavior as a predictor in Alzheimer disease.破坏性行为作为阿尔茨海默病的一个预测指标
Arch Neurol. 2007 Dec;64(12):1755-61. doi: 10.1001/archneur.64.12.1755.
10
Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress.帕金森病合并痴呆患者的神经精神症状:发生率、特征及相关的照料者压力
J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):36-42. doi: 10.1136/jnnp.2005.083113. Epub 2006 Jul 4.